Table 2.
PROMa | Number of studies | PROM development | Content validity | Structural validity | Internal consistency | Cross-cultural validity/measurement invariance | Reliability | Measurement error | Criterion validity | Hypotheses testing for construct validity | Responsiveness |
Adult Asthma Adherence Questionnaire | 1 | 0b | ?c/Bd | ?/B | −e/Cf | 0 | 0 | 0 | 0 | −/B | +g/B |
Adult AIDS Clinical Trials Group | 8 | 0 | ?/Dh | ?/B | +/Ai | 0 | 0 | 0 | 0 | ±j/C | +/C |
Antidepressant Adherence Scale | 1 | D | ?/D | 0 | −/D | 0 | 0 | 0 | 0 | −/C | 0 |
Adherence Barrier Questionnaire | 2 | D | 0 | ?/B | +/A | 0 | 0 | 0 | 0 | −/B | 0 |
Adherence tool for chronic myelomonocytic leukemia | 1 | D | 0 | 0 | −/C | 0 | 0 | 0 | 0 | −/D | −/D |
Adherence Evaluation of Osteoporosis Treatment Questionnaire-12 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/A | +/A |
Antipsychotic Medication Beliefs and Attitudes Scale | 1 | D | +/C | −/B | +/A | 0 | 0 | 0 | 0 | +/B | 0 |
Adherence to Pulmonary Rehabilitation Questionnaire | 1 | C | +/C | ?/B | +/D | 0 | 0 | 0 | 0 | 0 | 0 |
ARMSk | 1 | C | +/C | ?/B | +/A | 0 | ?/C | 0 | 0 | +/B | 0 |
ARMS-7 | 1 | 0 | ?/C | −/A | +/A | 0 | +/B | 0 | 0 | 0 | 0 |
ASKl-12 | 1 | 0 | 0 | ?/B | +/A | 0 | +/B | 0 | 0 | +/A | 0 |
ASK-20 | 3 | B | +/B | ?/B | +/D | 0 | +/B | 0 | 0 | ±/A | −/B |
Attitudes to mesalamine questionnaire | 1 | D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/A | +/A |
Adherence self-report questionnaire | 1 | 0 | +/C | 0 | 0 | 0 | −/D | 0 | 0 | 0 | −/B |
Axelsson et alm [39] | 1 | D | 0 | ?/B | +/A | 0 | 0 | 0 | 0 | +/C | 0 |
Basel Assessment of Adherence to Immunosuppressive Medications Scale | 1 | 0 | +/B | ?/B | +/D | —n | +/A | 0 | 0 | +/B | 0 |
Brief Evaluation of Medication Influences and Beliefs | 1 | D | ?/D | ?/C | −/D | 0 | ?/D | 0 | 0 | −/D | +/C |
Beliefs Related to Medication Adherence | 1 | D | ?/D | ?/D | +/D | 0 | 0 | 0 | 0 | +/D | 0 |
Brief Medication Adherence Scale | 1 | D | 0 | ?/B | ?/D | 0 | +/B | 0 | 0 | +/C | 0 |
Beliefs about Medication Compliance Scale | 1 | D | +/C | ?/B | +/A | 0 | 0 | 0 | 0 | 0 | 0 |
Brief Medication Questionnaire | 4 | D | ?/C | 0 | 0 | 0 | +/B | 0 | 0 | +/B | +/C |
Center for Adherence Support Evaluation Adherence Index | 2 | 0 | 0 | 0 | 0 | 0n | ?/D | 0 | 0 | +/B | −/B |
Chronic Disease Compliance Instrument | 3 | A | +/A | ?/B | +/B | —n | 0 | 0 | 0 | −/B | 0 |
CEAT-VIH | 1 | 0 | +/B | 0 | +/D | 0 | 0 | 0 | 0 | +/C | 0 |
Chaiyachatiet alm [40] | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −/C |
Compliance assessment | 1 | 0 | 0 | 0 | ?/D | 0 | 0 | 0 | 0 | +/B | 0 |
Cohort Study of Medication Adherence Among Older Adults self-report tool | 1 | D | 0 | ?/D | 0 | 0 | 0 | 0 | 0 | +/B | +/B |
CQRo | 4 | B | +/B | ?/B | +/A | 0n | ±/B | 0 | 0 | ±/B | +/A |
CQR-5 | 1 | 0 | +/A | +/D | +/A | 0 | 0 | 0 | 0 | +/B | −/B |
Da et alm [41] | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −/C | −/B |
DAIp | 1 | D | 0 | 0 | +/D | 0 | ?/D | 0 | 0 | +/B | 0 |
DAI-10 | 2 | 0 | 0 | 0 | +/C | 0 | 0 | 0 | 0 | ±/A | −/B |
DAI-9 | 1 | 0 | 0 | ?/C | 0 | 0 | −/D | 0 | 0 | −/D | 0 |
Diagnostic Adherence to Medication Scale | 1 | B | +/B | 0 | 0 | 0 | 0 | 0 | 0 | +/A | 0 |
Demirtas et alm [42] | 1 | B | +/B | ?/A | +/A | 0 | ?/C | 0 | 0 | +/C | 0 |
Danish version of Medication Adherence Report Scale-4 | 1 | 0 | ?/D | 0 | +/C | 0 | 0 | 0 | 0 | −/D | 0 |
Diabetes Management Questionnaire | 1 | D | ?/C | 0 | +/A | 0 | −/C | 0 | 0 | +/B | 0 |
Diabetes Medication Self-efficacy Scale | 2 | D | +/B | ?/B | +/D | 0n | +/B | 0 | 0 | +/C | −/B |
Environmental Barriers to Adherence Scale | 1 | 0 | 0 | 0 | +/A | 0 | ?/D | 0 | 0 | +/D | 0 |
Eye-Drop Satisfaction Questionnaire | 2 | D | +/C | ?/B | +/A | 0 | 0 | 0 | 0 | ?/C | 0 |
End-Stage Renal Disease Adherence Questionnaire | 2 | D | +/B | 0 | 0 | 0n | +/C | 0 | 0 | −/B | 0 |
Every Visit Adherence Questionnaire | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/D | 0 |
Five-dimension adherence model | 1 | D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/A |
Fredericksen et alm [249] | 1 | C | +/A | 0 | 0 | 0 | +/A | 0 | 0 | 0 | 0 |
General adherence tendency measure | 1 | D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −/B | −/B |
General Medicine Adherence Scale | 3 | C | +/B | +/A | +/A | 0n | ±/B | 0 | 0 | +/B | +/C |
Godin et alm [43] | 2 | C | ?/C | 0 | 0 | 0 | 0 | 0 | 0 | −/C | +/C |
GTCATq | 1 | D | ?/B | ?/D | −/B | 0 | ?/D | 0 | 0 | +/B | 0 |
GTCAT (reduced) | 2 | 0 | ?/B | −/C | −/A | 0 | +/B | 0 | 0 | −/B | 0 |
Hill-Bone Scale | 5 | B | +/A | ?/B | +/B | 0n | 0 | 0 | 0 | +/A | 0 |
Hill-Bone Scale (modified) | 1 | 0 | ?/C | 0 | −/D | 0n | 0 | 0 | 0 | 0 | 0 |
HIV Intention Measure | 1 | C | +/B | ?/B | +/A | 0 | 0 | 0 | 0 | +/C | 0 |
HIV Symptom Quality of Life Adherence Questionnaire | 1 | D | 0 | ?/B | +/C | 0 | 0 | 0 | 0 | +/B | 0 |
Iraqi Anti-Diabetic Medication Adherence Scale | 1 | C | ?/C | 0 | +/B | 0n | ?/C | 0 | 0 | +/B | +/C |
Item Response Theory-30 | 1 | B | +/B | ?/B | 0 | 0 | 0 | 0 | 0 | ?/C | +/B |
Immunosuppressant Therapy Adherence Scale | 2 | 0 | 0 | ?/B | +/D | 0n | 0 | 0 | 0 | ±/B | 0 |
Immunosuppressant Therapy Barrier Scale | 1 | C | +/B | ?/B | +/A | 0 | 0 | 0 | 0 | +/A | +/A |
Kennedy et alm [44] | 1 | D | +/B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Kerr et alm [45] | 1 | D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −/D | −/D |
Least absolute shrinkage and selection operator-10 | 1 | B | +/B | ?/B | 0 | 0 | 0 | 0 | 0 | ?/C | +/B |
Long-Term Medication Behaviour Self-Efficacy Scale | 1 | D | ?/D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Modified Drug Adherence Work-up Tool | 2 | 0 | ?/D | ?/D | +/D | 0 | 0 | 0 | 0 | −/B | +/B |
Medication Adherence Questionnaire | 1 | D | ?/D | 0 | +/D | 0n | +/D | 0 | 0 | 0 | 0 |
MAR-Scaler | 1 | C | ?/D | ?/B | −/A | 0 | −/D | 0 | 0 | +/D | 0 |
MAR-Scale (revised) | 2 | B | +/B | ?/B | +/A | 0 | 0 | 0 | 0 | +/B | 0 |
MARSs | 8 | D | +/D | ?/B | ±/A | 0n | ?/D | 0 | 0 | ±/B | ±/B |
MARS-10 | 1 | 0 | ?/D | ?/B | +/A | 0n | 0 | 0 | 0 | +/B | +/B |
MARS-5 | 8 | 0 | +/B | ?/B | +/B | 0n | ±/B | 0 | 0 | ±/A | ±/B |
MARS-9 | 2 | 0 | +/B | ?/B | +/A | 0 | −/B | 0 | 0 | ±/B | 0 |
MASESt | 2 | D | +/A | ?/B | +/A | 0 | −/D | 0 | 0 | ±/A | 0 |
MASES-R | 1 | 0 | 0 | ?/B | +/D | 0 | −/C | 0 | 0 | −/B | 0 |
Medication Adherence Self-Report Inventory | 6 | D | 0 | 0 | +/B | 0 | +/D | 0 | 0 | +/A | +/A |
Medication adherence scale | 1 | D | +/C | −/A | +/A | 0 | 0 | 0 | 0 | −/B | 0 |
Medication adherence survey | 1 | B | +/B | 0 | 0 | 0 | 0 | 0 | 0 | +/D | 0 |
Medication Adherence Estimation and Differentiation Scale | 1 | C | ?/B | +/A | +/A | 0 | 0 | 0 | 0 | +/D | −/A |
Medication Intake Survey-Asthma | 1 | B | +/B | 0 | 0 | 0 | −/B | 0 | 0 | +/B | 0 |
MMASu-4 | 18 | 0 | +/C | ?/B | −/B | 0 | ±/B | 0 | 0 | ±/A | −/B |
MMAS-7 | 1 | 0 | 0 | 0 | 0 | 0n | 0 | 0 | 0 | +/B | 0 |
MMAS-8 | 27 | 0 | +/B | ±/A | ±/A | 0n | +/B | 0 | 0 | ±/A | −/B |
MMAS-9 | 1 | 0 | 0 | +/A | −/A | 0 | ?/C | 0 | 0 | −/B | 0 |
Medication Nonpersistence Scale | 1 | C | ?/C | +/A | +/D | 0 | 0 | 0 | 0 | +/C | −/D |
Medical Outcomes Study General Adherence Scale | 1 | 0 | 0 | 0 | +/D | 0 | 0 | 0 | 0 | −/C | 0 |
Multiple Sclerosis Treatment Adherence Questionnaire | 1 | C | ?/B | 0 | −/A | 0 | 0 | 0 | 0 | +/A | 0 |
Outcome Expectations for Osteoporosis Medication Adherence Scale | 2 | D | +/B | ±/A | +/A | 0 | 0 | 0 | 0 | −/C | 0 |
Perceived Barriers to Antiretroviral Therapy Adherence Scale | 1 | B | +/C | ?/B | ?/C | 0n | −/C | 0 | 0 | +/C | 0 |
Pictographic Self-Efficacy Scale | 1 | D | +/B | 0 | −/A | 0 | −/D | 0 | 0 | −/B | 0 |
Patient Rating of Compliance Scale | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/B | 0 |
Patient Preference Questionnaire | 1 | D | +/D | 0 | +/D | 0 | 0 | 0 | 0 | 0 | 0 |
Probabilistic Medication Adherence Scale | 1 | C | ±/C | −/A | +/C | 0 | 0 | 0 | 0 | 0 | 0 |
Number of pills taken or prescribed | 2 | 0 | 0 | 0 | ?/D | 0 | −/D | 0 | 0 | ±/C | 0 |
Questionnaire for Adherence with Topical Treatments in Psoriasis | 1 | D | +/B | 0 | 0 | 0 | 0 | 0 | 0 | ±/D | 0 |
Question of Interest | 1 | 0 | ?/D | 0 | 0 | 0 | 0 | 0 | 0 | −/D | −/D |
SCIv | 2 | 0 | ?/C | +/A | 0 | 0 | −/B | 0 | 0 | ±/A | −/B |
SCI-R | 1 | 0 | +/B | ?/B | +/A | 0n | ?/D | 0 | 0 | +/D | +/D |
Strathclyde Compliance Risk Assessment Tool | 2 | 0 | 0 | 0 | +/B | 0 | 0 | 0 | 0 | +/B | +/B |
Summary of Diabetes Self-care Activities | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ±/C | 0 |
Self-Efficacy for Appropriate Medication Adherence Scale | 3 | B | +/B | ?/B | +/A | 0 | +/A | 0 | 0 | ±/A | 0 |
Self-efficacy scale | 1 | D | ?/B | ?/B | +/A | 0 | 0 | 0 | 0 | ?/D | 0 |
Self-report measures of adherence | 1 | 0 | 0 | 0 | 0 | 0 | ?/B | 0 | 0 | +/B | 0 |
Self-report on adherence | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −/C | +/C |
Self-Efficacy for Osteoporosis Medication Adherence Scale | 2 | D | +/B | −/A | +/A | 0 | 0 | 0 | 0 | +/C | 0 |
Self-Reported Adherence Questionnaire | 1 | 0 | D | 0 | 0 | 0 | 0 | 0 | 0 | ?/D | 0 |
Satisfaction with Iron Chelation Therapy | 1 | B | +/B | ?/B | +/A | 0 | 0 | 0 | 0 | +/A | 0 |
Sidorkiewicz et alm [46] | 1 | B | +/B | 0 | 0 | 0 | 0 | 0 | 0 | +/C | 0 |
Simplified Medication Adherence Questionnaire | 2 | D | ?/C | 0 | +/C | 0 | +/A | 0 | 0 | +/B | −/A |
Stages of Change Model Questionnaire | 2 | D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/C | 0 |
Special Projects of National Significance Adherence Survey | 1 | 0 | 0 | 0 | +/D | 0 | 0 | 0 | 0 | +/C | 0 |
Self-Rating Scale Item | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +/C | +/C |
Test of Adherence to Inhalers | 1 | B | ?/B | ?/B | +/D | 0 | +/A | 0 | 0 | −/C | −/A |
Tan et al [47] | 1 | C | ?/C | ?/B | +/A | 0 | +/A | 0 | 0 | +/B | 0 |
Treatment Adherence Survey-Patient Version | 1 | D | 0 | 0 | 0 | 0 | +/B | 0 | 0 | −/C | 0 |
Therapeutic Adherence Scale for Hypertensive Patients | 1 | 0 | 0 | +/A | +/A | 0 | 0 | 0 | 0 | +/B | −/B |
Topical Therapy Adherence Questionnaire | 1 | D | +/D | 0 | +/D | 0 | 0 | 0 | 0 | 0 | 0 |
Turcu-știolică et alm [48] | 1 | D | +/D | 0 | −/D | 0 | 0 | 0 | 0 | −/D | 0 |
Visual analog scale | 4 | 0 | 0 | 0 | 0 | 0 | −/D | 0 | 0 | +/B | 0 |
Validated Hemophilia Regimen Treatment Adherence Scale—On-Demand | 1 | D | +/D | 0 | +/B | 0 | +/B | 0 | 0 | ±/B | 0 |
Validated Hemophilia Regimen Treatment Regimen Treatment Adherence Scale-Prophylaxis | 1 | D | +/D | 0 | +/C | 0 | +/C | 0 | 0 | −/C | 0 |
Voils et alm [49] | 4 | C | +/B | +/A | +/A | 0n | −/A | 0 | 0 | ±/A | −/B |
Vreeman et alm [50] | 2 | C | ?/C | 0 | 0 | 0n | 0 | 0 | 0 | −/C | −/C |
Web-Ad-Q Questionnaire | 1 | C | +/C | 0 | 0 | 0 | +/D | 0 | 0 | +/C | 0 |
Wilson et alm [51] | 3 | B | +/B | 0 | +/A | 0 | 0 | 0 | 0 | +/D | −/A |
aPROM: patient-reported outcome measurement.
b0: Measurement properties were not assessed by the study.
c?: intermediate.
dB: moderate.
e−: insufficient.
fC: low.
g+: sufficient.
hD: very low.
iA: high.
j±: inconsistent.
kARMS: Adherence to Refills and Medications Scale.
lASK: Adherence Starts with Knowledge questionnaire.
mPROMs without proper names are labeled based on the last name of the first author who developed the instrument.
nOnly translation was done. Cross-cultural validation was not the aim of the study.
oCQR: Compliance Questionnaire on Rheumatology.
pDAI: Drug Attitude Inventory.
qGTCAT: Glaucoma Treatment Compliance Assessment Tool.
rMAR-Scale: Medication Adherence Reasons Scale.
sMARS: Medication Adherence Rating Scale.
tMASES: Medication Adherence Self-efficacy Scale.
uMMAS: Morisky Medication Adherence Scale.
vSCI: Self-Care Inventory.